Overactive Bladder
Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate - Abstract
November 29, 2013
Urinary bladder drugs - Abstract
November 28, 2013
Electrical and mechanical office-based neuromodulation - Abstract
November 26, 2013
Important drug-drug interactions for treatments that target overactive bladder syndrome - Abstract
November 26, 2013
Repeated botulinum toxin type A (Dysport®) injections for women with intractable detrusor overactivity: A prospective outcome study - Abstract
November 25, 2013
Cost-effectiveness of test phase implantation strategies for InterStim® sacral neuromodulation - Abstract
November 21, 2013
Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States - Abstract
November 18, 2013
How to define a refractory idiopathic overactive bladder? - Abstract
November 15, 2013
Solifenacin in women with de novo overactive bladder post TVT-O: Is it effective? - Abstract
November 15, 2013
Long-term adherence to antimuscarinic therapy in everyday practice: A systematic review - Abstract
November 11, 2013
Patient-reported outcome of solifenacin treatment among women experiencing urinary urgency and urgency incontinence - Abstract
November 8, 2013